{"id":2826,"date":"2019-10-08T15:03:15","date_gmt":"2019-10-08T13:03:15","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2826"},"modified":"2024-03-07T16:43:24","modified_gmt":"2024-03-07T15:43:24","slug":"hepato-biliary-pancreatic-pathology","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/translational-medicine-area\/digestive-system-diagnostics-pharmacogenetics-care-support-and-clinical-prevention-program-2\/hepato-biliary-pancreatic-pathology\/","title":{"rendered":"Hepato-biliary-pancreatic pathology"},"content":{"rendered":"\n

\n\t\tHepato-biliary-pancreatic pathology\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\tThis group’s main area of interest is the study of diseases associated with the liver, in particular complications involving liver transplants, cirrhosis, hepatitis B and C, liver and pancreatic cancer.
\nThe approach is mainly of a clinical nature, with patient studies and epidemiological (populational) studies on the characteristics that correlate with the prognoses, and the causes of treatment complications. The relevance of the group’s research is clear. On the one hand, pancreatic cancer has one of the worst prognoses due to it being difficult to diagnose, and on the other hand, due to the central position of the liver metabolism in the human body.\n

1344<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"18510464528_041ee45664\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tLiver transplantation
\nCirrhosis complications
\nTreatment of chronic hepatitis due to HCV and HBV
\nOncological hepatic surgery
\nSurgical treatment and early diagnosis of pancreatic cancer
\nEndoscopic ultrasound in hepatobiliary and pancreatic disorders\n\t\t\t\t\tSelected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t

Loras C, And\u00fajar X, Gornals JB, Sanchiz V, Brullet E, Sicilia B, Mart\u00edn Arranz MD, Naranjo A, Barrio J, Due\u00f1as C, Foruny JR, Busquets D, Monfort D, Pineda JR, Gonz\u00e1lez Huix F, P\u00e9rez Rold\u00e1n F, Pons V, Gonz\u00e1lez B, Reyes Moreno J, Sainz E, Guardiola J, Bosca Watts MM, Fern\u00e1ndez Ba\u00f1ares F, Mayor V, Esteve M, Grupo Espa\u00f1ol de Trabajo de la Enfermedad de Crohn Colitis Ulcerosa (GETECCU) Y. Self-expandable metal stents versus endoscopic balloon dilation for the treatment of strictures in Crohn’s disease (ProtDilat study): an open-label, multicentre, randomised trial<\/strong>. Lancet Gastroenterol. Hepatol. 2022;7(4):332-341. doi:10.1016\/S2468-1253(21)00386-1.<\/p>\n

Fav\u00e0 A, Donadeu L, Jouve T, Gonzalez Costello J, Llad\u00f3 L, Santana C, Toapanta N, Lopez M, Pernin V, Facundo C, Caba\u00f1as NS, Thaunat O, Crespo M, Llin\u00e0s L, Revuelta I, Sab\u00e9 N, Rombauts A, Calatayud L, Ardanuy C, Esperalba J, Fernandez C, Lozano JJ, Preyer R, Strecker K, Couceiro C, Garc\u00eda Romero E, Cachero A, Meneghini M, Torija A, Le Quintrec M, Melilli E, Cruzado JM, Polo C, Moreso F, Crespo E, Bestard O. A comprehensive assessment of long-term SARS-CoV-2-specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipients<\/strong>. Kidney Int. 2022;101(5):1027-1038. doi:10.1016\/j.kint.2021.12.029.<\/p>\n

Riera Mestre A, Cerd\u00e0 P, Guzm\u00e1n YC, Iriarte A, Torroella A, Mora Luj\u00e1n JM, Castellote J, Hessheimer A, Fondevila C, Llad\u00f3 L. Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review<\/strong>. J. Clin. Med. 2022;11(19):doi:10.3390\/jcm11195624.<\/p>\n

Hessheimer AJ, de la Rosa G, Gastaca M, Ru\u00edz P, Otero A, G\u00f3mez M, Alconchel F, Ram\u00edrez P, Bosca A, L\u00f3pez And\u00fajar R, Atutxa L, Royo Villanova M, S\u00e1nchez B, Santoyo J, Mar\u00edn LM, G\u00f3mez Bravo M\u00c1, Mosteiro F, Villegas Herrera MT, Villar Del Moral J, Gonz\u00e1lez Abos C, Vidal B, L\u00f3pez Dom\u00ednguez J, Llad\u00f3 L, Rold\u00e1n J, Justo I, Jim\u00e9nez C, L\u00f3pez Moncl\u00fas J, S\u00e1nchez Turri\u00f3n V, Rodr\u00edguez La\u00edz G, Velasco S\u00e1nchez E, L\u00f3pez Baena J\u00c1, Caralt M, Charco R, Tom\u00e9 S, Varo E, Mart\u00ed Cruchaga P, Rotellar F, Varona MA, Barrera M, Rodr\u00edguez Sanjuan JC, Brice\u00f1o J, L\u00f3pez D, Blanco G, Nu\u00f1o J, Pacheco D, Coll E, Dom\u00ednguez Gil B, Fondevila C. Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss<\/strong>. Am. J. Transplant. 2022;22(4):1169-1181. doi:10.1111\/ajt.16899.<\/p>\n

Rudler M, Hern\u00e1ndez Gea V, Procopet BD, Gir\u00e1ldez A, Amitrano L, Villanueva C, Iba\u00f1ez L, Silva Junior G, Genesca J, Bureau C, Trebicka J, Ba\u00f1ares R, Krag A, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira C, Canete N, Rodr\u00edguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernandez Guerra M, Sassatelli R, Dell’era A, Senzolo M, Abraldes JG, Romero G\u00f3mez M, Zipprich A, Casas M, Masnou H, Larrue H, Primignani M, Nevens F, Calleja JL, Schwarzer R, Jansen C, Robic MA, Conejo I, Mart\u00ednez Gonzalez J, Catalina MV, Albillos A, Alvarado E, Guardascione MA, Mallet M, Tripon S, Casanovas G, Bosch J, Garcia Pagan JC, Thabut D, for International Variceal Bleeding Observational Study Group: a Baveno Coopera . Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding<\/strong>. Gut. 2022;doi:10.1136\/gutjnl-2022-326975. I<\/p>\n\t\t\t\t\tSelected Projects<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t

18ACL021. EFECTOS SOBRE LA MORTALIDAD DE LA ADMINISTRACI\u00d3N DE ALB\u00daMINA EN PACIENTES CON CIRROSIS Y ENCEFALOPATIA HEP\u00c1TICA<\/strong> . Budget: 3475. 2018-2022. PI: Castellote Alonso, Jos\u00e9.<\/p>\n

19ACL227. ESTUDIO EN FASE II CON DOBLE ENMASCARAMIENTO, ALEATORIZADO DE GRUPOS PARALELOS PARA EVALUAR LA EFICACIA, LA SEGURIDAD Y LA TOLERABILIDAD DEL \u00c1CIDO OBETIC\u00d3LICO CUANDO SE ADMINISTRA EN COMBINACI\u00d3N CON BEZAFIBRATO EN SUJETOS CON COLANGITIS BILIAR PRIMARIA QUE TUVIERON UNA RESPUESTA INSUFICIENTE AL \u00c1CIDO URSODESOXIC\u00d3LICO O QUE NO PUDIERON TOLERARLO<\/strong> . Budget: 48956,4. 2019-2022. PI: Castellote Alonso, Jos\u00e9.<\/p>\n

MAR21016. Functional Immune-Monitoring of Virus-specific T and B-cell Responses in Solid Organ Transplant Recipients receiving SARS-CoV-2 Vaccination (MoniToR)<\/strong>. Fundaci\u00f3 La Marat\u00f3 de TV3. Budget: 31250. 2021-2023. PI: Llad\u00f3 Garriga, Laura.<\/p>\n\t\t\t\t\"Castellote\n

\n\t\tCastellote Alonso, Jos\u00e9\n\t<\/h4>\n

\n\t\t\n\t\tjcastellote@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tPrincipal investigators\n\t<\/h2>\n\t\t\t\t\"Castellote\n

\n\t\tCastellote Alonso, Jos\u00e9\n\t<\/h4>\n

\n\t\t\n\t\tjcastellote@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Joan-Berenguer-Gornals-Soler\"\n

\n\t\tGornals Soler, Joan Berenguer\n\t<\/h4>\n

\n\t\t\n\t\tjgornals@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"avatar\"\n

\n\t\tBusquets Barenys, Juli\n\t<\/h4>\n

\n\t\t\n\t\tjbusquets@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Laura-Llado-Garriga\"\n

\n\t\tLlad\u00f3 Garriga, Laura\n\t<\/h4>\n

\n\t\t\n\t\tlllado@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t\"Carme-Baliellas-Comellas\"\n

\n\t\tBaliellas Comellas, Carme\n\t<\/h4>\n

\n\t\t\n\t\tmbaliellas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tRELATED LINKS\n\t<\/h4>\n

\n\t\t\n\t\t@Laura_Llado_\n\t\t<\/a>\n\t<\/h4>\n

\n\t\tTeam\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tGroup leaders\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tPrincipal investigators\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tClinical researchers\t\t\t\t<\/a>\n\t\t\t\t\t\tGroup leaders\n\t\t\t\t\t\t\t\t\t\t\t